中國的藥品市場：策略性機會分析

中國的藥品市場：策略性機會分析 是由出版商Pharmalicensing Ltd.在2007年01月所出版的。 這份英文市場調查報告書包含97 pages 價格從美金1200起跳。

簡介

目錄

Abstract

China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around $US12 billion.

Factors fuelling the developmental growth and attracting foreign investors to the area include low labor costs, high quality clinical data and an abundance of R&D collaborative opportunities and facilities.

Global biotechnology within China has also undergone significant growth, promising enormous potential for new companies. Biotechnology companies in the country have already grown quicker than pharmaceutical companies.

The report discusses the whole of the Chinese pharmaceutical market, taking readers through the history and current state of the healthcare system to the regulations governing the country and its growing R&D capabilities. Detailing the driving forces behind the pharma market and including a full breakdown of the biopharma opportunities, including the contacts of active Chinese companies, the report is an essential resource to understand and access this lucrative market.

Reasons to purchase this report:

• Identify key partners
• Assess the current market opportunity
• Learn how newly implemented government changes have altered the face of the industry
• Understand the organization and success of clinical trials in China
• Create strategies for profitable market access into China

The Chinese government also plays an instrumental role in the pharmaceutical development of China. The introduction of WTO guidelines and protection for intellectual property rights has caused a shift in the company structures of China, forcing some to close business or enter into new collaborations.

Ideally suited for individuals wishing to introduce their companies into this emerging market or review the opportunities available, this report provides a perfect resource to identify the current pattern of the market and understand the regulations that operate within the country.

Table of Contents

1. Introduction

2. The Chinese healthcare system

• 2.1. A historical perspective
• 2.2. China' s healthcare system: Reforms
  • 2.2.1. The basic trend of the system reform: Commercialization and market orientation
  • 2.2.2. Achievements in health system reform
  • 2.2.3. Defects in the design of the new rural cooperative medical system

3. The Chinese pharmaceutical industry

• 3.1. History
• 3.2. Industry growth
• 3.3. Pharmaceutical trade (exports and imports)
• 3.4. The pharmaceutical distribution structure in China
• 3.5. Traditional Chinese medicine
  • 3.5.1. Modernization of Chinese medicine
  • 3.5.2. Drawbacks of TCM
  • 3.5.3. TCM worldwide

4. Driving forces behind the Chinese pharmaceutical market

• 4.1. Issues and opportunities in the pharmaceutical market
  • 4.1.1. SWOT analysis
• 4.2. Effect of the Chinese macro-environment on the pharmaceutical industry: A PEST analysis
  • 4.2.1. Political
  • 4.2.2. Economic
  • 4.2.3. Sociological
  • 4.2.4. Technological
  • 4.2.5. The urban-rural divide
  • 4.2.6. Steep market growth
  • 4.2.7. First-class biopharmaceutical institutions
  • 4.2.8. Good manufacturing practices
  • 4.2.9. Huge market potential
  • 4.2.10. Strong support from the Government
  • 4.2.11. Expansion into rural areas
  • 4.2.12. Social culture
  • 4.2.13. The trend toward self-medication

5. Health insurance in China

• 5.1. Government insurance
  • 5.1.1. The rural health protection system
  • 5.1.2. The urban health protection system
• 5.2. Commercial medical insurance in China
• 5.3. Health insurance take-up in China

6. Regulatory environment

• 6.1. Chinese pharmaceutical regulations: A historical perspective
• 6.2. Brief developmental history
• 6.3. Drug regulatory structure and functions
  • 6.3.1. Ministry of Public Health
  • 6.3.2. State Economic Trade Commission
• 6.4. State Food and Drug Administration
  • 6.4.1. New regulations on drug importation
• 6.5. Responsibilities of the SFDA
• 6.6. The registration process- medical devices
  • 6.6.1. Document preparation (stage one)
    • 6.6.1.1. SFDA registration form
    • 6.6.1.2. Legal production qualification
    • 6.6.1.3. Business license for the Chinese agent registering the product
    • 6.6.1.4. Marketing approval from the country of origin
    • 6.6.1.5. Product standards
    • 6.6.1.6. Operation or user manual
    • 6.6.1.7. Test report
    • 6.6.1.8. Clinical trial report
    • 6.6.1.9. Quality guarantee letter
    • 6.6.1.10. Agent authorization letter
    • 6.6.1.11. After-sales authorization
    • 6.6.1.12. Self-guarantee declaration
  • 6.6.2. Type testing and clinical trials (stage two)
    • 6.6.2.1. Type testing
    • 6.6.2.2. Clinical trials
  • 6.6.3. Registration submission (stage three)
  • 6.6.4. Issuance of the registration certificate (stage four)
  • 6.6.5. Registration procedure
  • 6.6.6. China Compulsory Certificate
• 6.7. The registration process- pharmaceuticals
• 6.8. A few practical points regarding the management of SFDA registration
  • 6.8.1. Complicated process
  • 6.8.2. Lengthy process
  • 6.8.3. Consultant support
  • 6.8.4. Product packaging compliance

7. Legal reform: IPR

• 7.1. Patent protection
  • 7.1.1. China' s accession into the WTO
  • 7.1.2. Impact of IPR and regulatory changes
  • 7.1.3. Impact on the industry

8. Research and development in China

• 8.1. Domestic R&D

相關商品

製藥企業相關市場調查報告書

生物標記相關合作契約
Biomarker Partnering Terms and Agreements
價格 : US $ 2695
出版日期 : 2012年02月

最佳實務：轉譯研究-朝向產業轉換前進
Best Practices: Translational Research - Positive Steps on the Path to Industry Transformation
價格 : US $ 4500
出版日期 : 2011年12月

製藥產業的合作，授權，投資，收購與合併交易趨勢:2011年12月
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011
價格 : US $ 1000
出版日期 : 2011年12月

Pharmalicensing Ltd.發行的製藥相關市場調查報告書

藥品事業發展授權合約（第3版）

The Licensing Agreement in Pharmaceutical Business Development (3rd Edition)

價格 : US $ 995

出版日期 : 2007年07月

新藥早期研發階段及新藥開發階段的企業聯盟

Early Stage and Discovery Deals: Strategy, Structure and Payment Terms 2nd Edition

價格 : US $ 2695

出版日期 : 2006年12月

醫院、意外及外傷治療藥之夥伴交易與合作趨勢

Partneringdesk Deals and alliances in hospital, accident and trauma

價格 : US $ 2495

出版日期 : 2006年04月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!